142 related articles for article (PubMed ID: 6170739)
1. Endogenous myelin basic protein-serum factors (MBP-SFs) and anti-MBP antibodies in humans. Occurrence in sera of clinically well subjects and patients with multiple sclerosis.
Paterson PY; Day ED; Whitacre CC; Berenberg RA; Harter DH
J Neurol Sci; 1981 Oct; 52(1):37-51. PubMed ID: 6170739
[TBL] [Abstract][Full Text] [Related]
2. Endogenous myelin basic protein-serum factors (MBP-SFs) in Lewis rats. Evidence for their heterogeneity and reactivity with anti-MBP antibodies of different affinities.
Day ED; Varitek VA; Paterson PY
J Neurol Sci; 1981 Jan; 49(1):1-17. PubMed ID: 6162918
[TBL] [Abstract][Full Text] [Related]
3. Endogenous myelin basic protein-serum factors (MBP-SFS) and anti-MBP antibodies in a patient with post-herpes simplex virus acute disseminated encephalomyelitis.
Rabinowitz SG; Day ED; Paterson PY; Koenig H
J Neurol Sci; 1983; 60(3):393-400. PubMed ID: 6195314
[TBL] [Abstract][Full Text] [Related]
4. Molecular and cellular determinants of neuroimmunologic inflammatory disease.
Paterson PY
Fed Proc; 1982 Jul; 41(9):2569-76. PubMed ID: 6177557
[TBL] [Abstract][Full Text] [Related]
5. Myelin basic protein-reactive autoantibodies in the serum and cerebrospinal fluid of multiple sclerosis patients are characterized by low-affinity interactions.
O'Connor KC; Chitnis T; Griffin DE; Piyasirisilp S; Bar-Or A; Khoury S; Wucherpfennig KW; Hafler DA
J Neuroimmunol; 2003 Mar; 136(1-2):140-8. PubMed ID: 12620653
[TBL] [Abstract][Full Text] [Related]
6. An extensive search for autoantibodies to myelin basic protein in cerebrospinal fluid of non-multiple-sclerosis patients: implications for the pathogenesis of multiple sclerosis.
Warren KG; Catz I
Eur Neurol; 1999; 42(2):95-104. PubMed ID: 10473981
[TBL] [Abstract][Full Text] [Related]
7. Intrathecal synthesis of autoantibodies to myelin basic protein in multiple sclerosis.
Catz I; Warren KG
Can J Neurol Sci; 1986 Feb; 13(1):21-4. PubMed ID: 2420428
[TBL] [Abstract][Full Text] [Related]
8. Autoantibodies to myelin basic protein within multiple sclerosis central nervous system tissue.
Warren KG; Catz I
J Neurol Sci; 1993 Apr; 115(2):169-76. PubMed ID: 7683331
[TBL] [Abstract][Full Text] [Related]
9. Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study.
Reindl M; Linington C; Brehm U; Egg R; Dilitz E; Deisenhammer F; Poewe W; Berger T
Brain; 1999 Nov; 122 ( Pt 11)():2047-56. PubMed ID: 10545390
[TBL] [Abstract][Full Text] [Related]
10. Autoantibodies to myelin basic protein are not present in the serum and CSF of MS patients.
Brokstad KA; Page M; Nyland H; Haaheim LR
Acta Neurol Scand; 1994 Jun; 89(6):407-11. PubMed ID: 7526591
[TBL] [Abstract][Full Text] [Related]
11. CSF antibodies to myelin basic protein and to myelin-associated glycoprotein in multiple sclerosis. Evidence of the intrathecal production of antibodies.
Wajgt A; Górny M
Acta Neurol Scand; 1983 Nov; 68(5):337-43. PubMed ID: 6198864
[TBL] [Abstract][Full Text] [Related]
12. Antibody to myelin basic protein in extracts of multiple sclerosis brain.
Bernard CC; Randell VB; Horvath LB; Carnegie PR; Mackay IR
Immunology; 1981 Jul; 43(3):447-57. PubMed ID: 6166547
[TBL] [Abstract][Full Text] [Related]
13. Are anti-brain antibodies in multiple sclerosis directed to myelin basic protein? Studies employing the Shiverer mouse mutant.
Ryberg B; Jacque C
Acta Neurol Scand; 1986 Mar; 73(3):247-52. PubMed ID: 2424259
[TBL] [Abstract][Full Text] [Related]
14. Do antibodies to myelin basic protein isolated from multiple sclerosis cross-react with measles and other common virus antigens?
Bernard CC; Townsend E; Randell VB; Williamson HG
Clin Exp Immunol; 1983 Apr; 52(1):98-106. PubMed ID: 6190599
[TBL] [Abstract][Full Text] [Related]
15. Antimyelin antibodies and the risk of relapse in patients with a primary demyelinating event.
Rauer S; Euler B; Reindl M; Berger T
J Neurol Neurosurg Psychiatry; 2006 Jun; 77(6):739-42. PubMed ID: 16705196
[TBL] [Abstract][Full Text] [Related]
16. Effect of methylprednisolone on CSF IgG parameters, myelin basic protein and anti-myelin basic protein in multiple sclerosis exacerbations.
Warren KG; Catz I; Jeffrey VM; Carroll DJ
Can J Neurol Sci; 1986 Feb; 13(1):25-30. PubMed ID: 2420429
[TBL] [Abstract][Full Text] [Related]
17. Serum and cerebrospinal fluid antibodies against myelin basic protein and their IgG subclass distribution in multiple sclerosis.
García-Merino A; Persson MA; Ernerudh J; Díaz-Gil JJ; Olsson T
J Neurol Neurosurg Psychiatry; 1986 Sep; 49(9):1066-70. PubMed ID: 2428940
[TBL] [Abstract][Full Text] [Related]
18. Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis.
Zhang J; Markovic-Plese S; Lacet B; Raus J; Weiner HL; Hafler DA
J Exp Med; 1994 Mar; 179(3):973-84. PubMed ID: 7509366
[TBL] [Abstract][Full Text] [Related]
19. Synthetic peptide specificity of anti-myelin basic protein from multiple sclerosis cerebrospinal fluid.
Warren KG; Catz I
J Neuroimmunol; 1992 Jul; 39(1-2):81-9. PubMed ID: 1377712
[TBL] [Abstract][Full Text] [Related]
20. Anti-myelin antibodies modulate clinical expression of childhood multiple sclerosis.
O'Connor KC; Lopez-Amaya C; Gagne D; Lovato L; Moore-Odom NH; Kennedy J; Krupp L; Tenembaum S; Ness J; Belman A; Boyko A; Bykova O; Mah JK; Stoian CA; Waubant E; Kremenchutzky M; Ruggieri M; Bardini MR; Rensel M; Hahn J; Weinstock-Guttman B; Yeh EA; Farrell K; Freedman MS; Iivanainen M; Bhan V; Dilenge M; Hancock MA; Gano D; Fattahie R; Kopel L; Fournier AE; Moscarello M; Banwell B; Bar-Or A
J Neuroimmunol; 2010 Jun; 223(1-2):92-9. PubMed ID: 20381173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
